Literature DB >> 1700543

Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine.

C Carrillo1, J Plana, R Mascarella, J Bergadá, F Sobrino.   

Abstract

A plaque-purified preparation of foot-and-mouth disease virus (FMDV) of serotype C1 (C-S8c1-1), grown in cell culture, was used to infect nonimmunized pigs. No variant genomes were detected in the average populations of 50 viruses isolated from infected animals by direct RNA sequencing of the carboxy-terminal half of the VP1 gene. However, a mutant with altered phenotypic properties was present in low proportion in an infected animal. The frequency of mutants resistant to neutralization by SD6 monoclonal antibody (MAb) [SD6 epitope MAb-resistant mutants (MARMs)], directly estimated in virus from lesions of infected animals (without passage in cell culture), depended on the procedure used for its determination and ranged from 2.9 x 10(-6) (when the virus was incubated with the MAb prior to plating) to 2.6 x 10(-5) (when incubation with MAb was avoided and the MAb was maintained in the agar overlay of the titration assay). Such a difference was not found for C-S8c1-1, which consistently showed frequencies of about 4 x 10(-5). In addition, the repertoire of amino acid substitutions was similar among SD6 epitope MARMs isolated directly both from vesicles of infected animals and from C-S8c1-1. Thus, in spite of the conservation of the average sequence in the region of VP1 RNA analyzed, antigenic heterogeneity has been found in viral populations of FMDV upon replication in nonimmunized swine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700543     DOI: 10.1016/0042-6822(90)90162-k

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Antigenic stability of foot-and-mouth disease virus variants on serial passage in cell culture.

Authors:  M J Gonzalez; J C Saiz; O Laor; D M Moore
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 3.  Molecular evolution of aphthoviruses.

Authors:  E Domingo; M G Mateu; C Escarmís; E Martínez-Salas; D Andreu; E Giralt; N Verdaguer; I Fita
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

4.  Hyper-antigenic variation occurs with human rhinovirus type 17.

Authors:  L J Patterson; V V Hamparian
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus.

Authors:  M A Martínez; N Verdaguer; M G Mateu; E Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

6.  Unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1.

Authors:  E Yuste; C López-Galíndez; E Domingo
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Antigenic analysis of type O foot-and-mouth disease virus in the persistently infected bovine.

Authors:  J S Salt; A R Samuel; R P Kitching
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Genetic and phenotypic variation of foot-and-mouth disease virus during serial passages in a natural host.

Authors:  C Carrillo; Z Lu; M V Borca; A Vagnozzi; G F Kutish; D L Rock
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

9.  Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades.

Authors:  M A Martínez; J Dopazo; J Hernández; M G Mateu; F Sobrino; E Domingo; N J Knowles
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification.

Authors:  N Sevilla; E Domingo
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.